Tarsus Pharmaceuticals (TARS) Return on Invested Capital (2020 - 2026)

Tarsus Pharmaceuticals' Return on Invested Capital history runs 5 years deep, the most recent figure standing at 0.0% for Q1 2026.

• In Q1 2026, Return on Invested Capital changed N/A year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed N/A YoY), while the FY2025 annual figure was 0.0%, changed N/A from the prior year.
• Return on Invested Capital was 0.0% for Q1 2026 at Tarsus Pharmaceuticals, up from 0.01% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q1 2026 to a low of 0.01% in Q2 2023.
• Historically, Return on Invested Capital has averaged 0.0% across 3 years, with a median of 0.0% in 2022.
• Biggest YoY gain for Return on Invested Capital was 0 bps in 2022; the steepest drop was 0 bps in 2022.
• A 3-year view of Return on Invested Capital shows it stood at 0.0% in 2022, then plunged by 79 bps to 0.01% in 2023, then soared by 75 bps to 0.0% in 2026.
• The last three Return on Invested Capital figures came in at 0.0% (Q1 2026), 0.01% (Q2 2023), and 0.0% (Q1 2023), per Business Quant data.